IJFANS International Journal of Food and Nutritional Sciences

ISSN PRINT 2319 1775 Online 2320-7876

Covid-19 Patients with Rhino-Orbito-Cerebral Mucormycosis (Black Fungus) in Western U.P., India

Main Article Content

Dr. Tarun Malhotra1 , Dr. Abhinav Raj2 , Dr. Sushil Gaur3 * , Dr. Samridhi Mishra4 , Dr. Ravi Gupta5

Abstract

The rare, rapidly lethal condition known as mucormycosis (sometimes known as "black fungus") is brought on by a saprophytic fungus in the mucorales family. The only accessible tool is early diagnosis and quick medical and surgical treatment. The rhino-orbito- cerebral subtype is the most prevalent. During the second wave of COVID 19, we noticed a dramatic increase in mucormycosis infections in India. This required a thorough analysis of the mucormycosis pandemic in COVID-19. A retrospective multi-centric investigation was undertaken on 60 patients of rhino-orbito-cerebral mucormycosis with current or recent COVID19 positive status that presented to us between April and May, 2021, in Western Uttar Pradesh. All of the patients had Type 2 Diabetes Mellitus or a history of recently using significant dosages of steroids. The pathogenicity of the Delta strain B1.617.2 is a substantial contributor. By considerably reducing the number of days of liposomal amphotericin B therapy, FESS with sino-nasal debridement significantly reduces mortality and overall treatment costs. The key to reducing mortality and morbidity continues to be early diagnosis, timely medical and surgical therapy, blood sugar control, and avoiding the use of excessive doses of steroids.

Article Details